During his time at Hologic, Eric B. Compton participated in various stock compensation packages, reflecting his strong belief in performance-based incentives. His most significant stock holdings occurred between 2019 and 2021, where monthly fluctuations showed values typically around $10 million....
During his time at Hologic, Eric B. Compton participated in various stock compensation packages, reflecting his strong belief in performance-based incentives. His most significant stock holdings occurred between 2019 and 2021, where monthly fluctuations showed values typically around $10 million. Notably, he observed a steady decrease in stock values from over $10 million earlier in 2020 to just under $5 million by late 2023. This decline wasn't uncommon, as the volatility of healthcare stocks often mirrors market conditions. Before stepping down in December 2017, Eric's wealth was closely tied to Hologic's successful financial performance, demonstrating his commitment to the company's growth. His decision to hold a substantial portion of his compensation in stock underlines a corporate culture that values alignment with shareholder interests.